Combinations comprising epothilones and pharmaceutical uses thereof
AssigneeNovartis AG
InventorsJohn David Rothermel, Markus Wartmann, Jeanette Marjorie Wood
Life of this patent
Estimating the term…
Loading patent…
AssigneeNovartis AG
InventorsJohn David Rothermel, Markus Wartmann, Jeanette Marjorie Wood
Estimating the term…
The invention relates to a combination which comprises (a) a bisphosphonate, a platinum compound or a vasculostatic compound and (b) an epothilone derivative of formula I wherein A represents O or NRN, wherein RN is hydrogen or lower alkyl, R is hydrogen or lower alkyl, and Z is O or a bond, in which the active ingredients (a) and (b) are present in each case in free form or in the form of a pharmaceutically acceptable salt and optionally at least one pharmaceutically acceptable carrier for simultaneous, separate or sequential use, in particular for the delay of progression or treatment of a proliferative disease, especially a solid tumor disease; a pharmaceutical composition, a commercial package or product comprising such a combination; the use of such a combination for the preparation of a medicament for the delay of progression or treatment of a proliferative disease and to a method of treatment of a warm-blooded animal.
A combination which comprises (a) a vasculostatic compound which is a VEGFR inhibitor and (b) an epothilone derivative of formula I
A commercial package comprising (a) a vasculostatic compound which is a VEGFR inhibitor and (b) an epothilone derivative of formula I
Dependencies are inferred from the claim text.